Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 3, 2012, Pages 353-361

  Rodriguez Blanco, Teresa ^a   Vila Corcoles, Angel ^b   De Diego, Cinta ^b   Ochoa Gondar, Olga ^b   Valdivieso, Empar ^b   Bobe, Francesc ^b   Morro, Amalia ^b   Hernández, Nuria ^b   Martin, Ana ^b   Calamote, Filomena ^b   Clotas, Lourdes ^b   Herreros, M Isabel ^b   Saun, Neus ^b  

^a Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Diabetes mellitus; Effectiveness; Elderly; Influenza vaccine; Mortality

Indexed keywords

AGED; ARTICLE; ATTRIBUTABLE RISK; CAUSE OF DEATH; COHORT ANALYSIS; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; ELDERLY CARE; FEMALE; FOLLOW UP; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK REDUCTION; SEASONAL INFLUENZA; SEASONAL VARIATION; SPAIN; WINTER;

EID: 84860363172     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.8.3.18548     Document Type: Article

References (38)

1. Heymann AD, Shapiro Y, Chodick G, Shalev V, Kokia E, Kramer E, et al. Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care 2004; 27: 2581-4; PMID:15504989; http://dx.doi.org/10.2337/diacare.27.11.2581
2. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB & Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004; 53(RR-6):1-40; PMID:15163927
3. WHO. Influenza vaccines. Recommendations for the use of inactivated influenza vaccines and other preventive measures. Wkly Epidemiol Rec 2000; 75:281-8.
4. Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004; 292:2089-95; PMID:15523069; http://dx.doi.org/10.1001/jama.292.17.2089
5. Smith SA, Poland GA & American Diabetes Association. Influenza and pneumococcal immunization in diabetes. Diabetes Care 2004; 27(Suppl 1):S111-3; PMID:14693944; http://dx.doi.org/10.2337/diacare.27.2007.S111
6. Colquhoun AJ, Nicholson KG, Botha JL, Raymond NT. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 1997; 119:335-41; PMID:9440437; http://dx.doi.org/10.1017/ S095026889700825X
7. Wang CS,Wang ST, Lai CT, Lin LJ, Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007; 25:1196-203; PMID:17097773; http://dx.doi.org/10.1016/j.vaccine.2006.10.015
8. Örtqvist A, Granath F, Askling J, Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 2007; 30:407-8; PMID:17766629; http://dx.doi.org/10.1183/ 09031936.00135306
9. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373-81; PMID:17914038; http://dx.doi.org/10.1056/NEJMoa070844
10. Voordouw BC, van der Linden PD, Simonian S, van der Lei J, Sturkenboom MC, Stricker BH. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med 2003; 163:1089-94; PMID:12742808; http://dx.doi.org/10.1001/archinte.163.9.1089
11. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158:1769-76; PMID:9738606; http://dx.doi.org/10.1001/archinte.158.16.1769
12. Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001; 184:665-70; PMID:11517426; http://dx.doi.org/10.1086/ 323085
13. Looijmans-Van den Akker I, Verheij TJ, Buskens E, Nichol KL, Rutten GE, Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 2006; 29:1771-6; PMID:16873778; http://dx.doi.org/10.2337/dc05-2517
14. Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004; 190:1-10; PMID:15195237; http://dx.doi.org/10.1086/421274
15. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66; PMID:17897608; http://dx.doi.org/10.1016/ S1473-3099(07)70236-0
16. Vila-Córcoles A, Rodríguez T, de Diego C, Ochoa O, Valdivieso A, Salsench E, et al & EPIVAC Study Group. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine 2007; 25:6699-707; PMID:17698263; http://dx.doi.org/10.1016/j.vaccine.2007.07.015
17. Vila-Córcoles A, Ochoa O, de Diego C, Valdivieso A, Herreros I, Bobé F, et al. Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease. Int J Clin Pract 2008; 62:10-7; PMID:17573840; http://dx.doi.org/10.1111/j.1742-1241.2007.01414.x
18. de Diego C, Vila-Córcoles A, Ochoa O, Rodríguez-Blanco T, Salsench E, Hospital I, et al & EPIVAC Study Group. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J 2009; 30:209-16; PMID:18997178; http://dx.doi.org/10.1093/ eurheartj/ehn498
19. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998; 317:1309-12; PMID:9804726; http://dx.doi.org/10.1136/bmj.317.7168.1309
20. Rosenbaum PR, Rubin DB. Reducing bias en observational studies using subclassification on the propensity score. J Am Stat Assoc 1984; 79:516-24; http://dx.doi.org/10.2307/2288398
21. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-81; PMID:9802183; http://dx.doi.org/10.1002/(SICI)1097-0258(19981015)17: 19〈2265::AIDSIM918〉3.0.CO;2-B
22. Singer JD, Willett JB. Fitting basic discrete-time hazard models. In: Applied Longitudinal data analysis: modelling change and event occurrence. New York: Oxford University Press, 2003; pp 357-467.
23. Hosmer DW, Lemeshow SA. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons, Inc., 2000.
24. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165:265-72; PMID:15710788; http://dx.doi.org/10.1001/archinte.165.3.265
25. Hak E, Buskens E, van Essen GA, de Bakker DH, Grobbee DE, Tacken MA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005; 165:274-80; PMID:15710789; http://dx.doi.org/10.1001/archinte.165.3.274
26. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007; 28:1205-10; PMID:17440221; http://dx.doi.org/10.1093/eurheartj/ehm035
27. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I: basic concepts and first analyses. Br J Cancer 2003; 89:232-8; PMID:12865907; http://dx.doi.org/10.1038/sj.bjc.6601118
28. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27; PMID:7661497
29. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20:1831-6; PMID:11906772; http://dx.doi.org/10.1016/S0264-410X(02) 00041-5
30. Sarría-Santamera A, Timoner J. Influenza vaccination in old adults in Spain. Eur J Public Health 2003; 13:133-7; PMID:12803411; http://dx.doi.org/10.1093/eurpub/13.2.133
31. Jiménez-García R, Mayo-Montero E, Hernández-Barrera V, Garrido PC, Martínez-Hernandez D, de Miguel AG. Influenza vaccination among diabetic adults: related factors and trend from 1993 to 2001 in Spain. Diabetes Care 2005; 28:2031-3; PMID:16043751; http://dx.doi.org/10.2337/diacare. 28.8.2031
32. Fukuda K, Cox NJ, Bridges CB, Levandowski RA. Influenza vaccine-inactivated. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: Saunders, 2004.
33. WHO. Recommended composition of influenza virus vaccines for use in the 2003 influenza season. Wkly Epidemiol Rec 2002; 77:341-8; PMID:12407831
34. WHO. Influenza in the world. 1 October 2002-30 September 2003. Wkly Epidemiol Rec 2003; 78:393-6; PMID:14631597
35. WHO. Influenza in the world. Wkly Epidemiol Rec 2004; 79:385-8; PMID:15573938
36. WHO. Recommended composition of influenza virus vaccines for use in the 2006 influenza season. Wkly Epidemiol Rec 2005; 80:342-7; PMID:16240985
37. Szklo M. Nieto J. Epidemiology. Beyond the Basics. Aspen Publishers, Inc., 2000.
38. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66; PMID:17897608; http://dx.doi.org/10.1016/ S1473-3099(07)70236-0